Anavex Life Sciences Corp.
Last updated September 27, 2026
Organization details
- Legal name
- Anavex Life Sciences Corp.
- Ownership
- Public
- Status
- Active
- Headquarters country
- United States
- Ticker symbol
- AVXL
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001314052
Board of directors
-
Athanasios Skarpelos · DirectorSince 2023
-
Axel Paeger · DirectorSince 2026
-
Christopher U. Missling · Director · President and CEOSince 2023
-
Claus Vander Velden · DirectorSince 2023
-
Jiong Ma · DirectorSince 2023
-
Peter D.o. Donhauser · DirectorSince 2023
-
Steffen Thomas · DirectorSince 2023
Chief executives
Christopher U. Missling
· President and CEO
Dates unknown
Board connections
1 of this board's directors also sit on 2 other boards.
- via Jiong Ma
- via Jiong Ma
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $0
- 0 purchases by 0 insiders
- Sold, last 12 months
- $0
- 0 sales by 0 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Sep 11, 2025 | Christopher U. Missling Director, Officer (President and CEO) | Option exercise | +187,500 | $5.04 | $945,000 |
| Sep 11, 2025 | Christopher U. Missling Director, Officer (President and CEO) | Shares withheld for tax | −145,048 | $9.58 | $1,389,560 |
| Jun 5, 2025 | Steffen Thomas Director | Option exercise | +50,000 | $1.76 | $88,000 |
| Jun 5, 2025 | Steffen Thomas Director | Shares withheld for tax | −11,349 | $7.75 | $87,955 |
| Mar 24, 2025 | Christopher U. Missling Director, Officer (President and CEO) | Option exercise | +500,000 | $0.92 | $460,000 |
| Mar 24, 2025 | Christopher U. Missling Director, Officer (President and CEO) | Shares withheld for tax | −282,497 | $9.63 | $2,720,446 |
| Jun 14, 2024 | Peter D.o. Donhauser Director | Open-market purchase | +2,835 | $3.64 | $10,319 |
| May 15, 2024 | Steffen Thomas Director | Open-market purchase | +5,000 | $4.52 | $22,600 |
| Mar 28, 2024 | Christopher U. Missling Director, Officer (President and CEO) | Option exercise | +73,380 | $1.32 | $96,862 |
| Mar 28, 2024 | Christopher U. Missling Director, Officer (President and CEO) | Open-market sale | −73,380 | $5.11 | $374,972 |
| Jun 29, 2023 | Christopher U. Missling Director, Officer (President and CEO) | Option exercise | +232,000 | $1.60 | $371,200 |
| Jun 28, 2023 | Christopher U. Missling Director, Officer (President and CEO) | Option exercise | +268,000 | $1.60 | $428,800 |
| Jun 28, 2023 | Christopher U. Missling Director, Officer (President and CEO) | Open-market sale | −268,000 | $7.98 | $2,138,640 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.